Key result
Pregnancy-adapted YEARS algorithm safely rules out PE while avoiding CT angiography in ~39% of patients.
Why the study?
Diagnostic management of pregnancy-related venous thromboembolism is challenging, and current guidelines vary greatly in diagnosing pulmonary embolism in pregnancy due to scarce and weak evidence.
What are the contemporary best practices and guideline recommendations for the diagnosis, treatment, delivery management, and secondary prevention of pulmonary embolism during pregnancy and the postpartum period?
What are the contemporary best practices and guideline recommendations for the diagnosis, treatment, delivery management, and secondary prevention of pulmonary embolism during pregnancy and the postpartum period?
This clinical review synthesizes divergent international guidelines and recent prospective trial evidence, establishing the pregnancy-adapted YEARS algorithm as a safe, efficient diagnostic tool that spares 39% of pregnant women with suspected PE from radiation-exposing CTPA while detailing best practices for peripartum LMWH anticoagulation.
Answers are grounded in this paper and cite their sources.
May support YEARS algorithm adoption to limit CTPA in pregnancy; leaves open need for larger prospective validation.
Approximately 1-2 per 1000 pregnancies are complicated by venous thromboembolism (VTE). VTE includes deep vein thrombosis (DVT) and pulmonary embolism (PE) and the diagnostic management of pregnancy-related VTE is challenging. Current guidelines vary greatly in their approach to diagnosing PE in pregnancy as they base their recommendations on scarce and weak evidence. The pregnancy-adapted YEARS diagnostic algorithm is well tolerated and is the most efficient diagnostic algorithm for pregnant women with suspected PE, with 39% of women not requiring computed tomographic pulmonary angiography. Low-molecular-weight heparin is the first-choice anticoagulant treatment in pregnancy and should be continued until 6 weeks postpartum and for a minimum of 3 months. Direct oral anticoagulants should be avoided in women who want to breastfeed. Management of delivery needs a multidisciplinary approach in order to decide on an optimal delivery plan. Neuraxial analgesia can be given in most patients, provided time windows since last low-molecular-weight heparin dose are respected. Women with a history of VTE are at risk of recurrence during pregnancy and in the postpartum period. Therefore, in most women with a history of VTE, thromboprophylaxis in subsequent pregnancies is indicated.
No takes yet. Share an insight, caveat, or question.
Wiegers et al. (2020) conducted a review in Pregnancy-related pulmonary embolism and venous thromboembolism. Pregnancy-adapted YEARS diagnostic algorithm and low-molecular-weight heparin (LMWH) anticoagulation vs. Standard imaging strategies (CTPA or V/Q scanning), revised Geneva score algorithm, unfractionated heparin, vitamin K antagonists, or direct oral anticoagulants was evaluated. The pregnancy-adapted YEARS diagnostic algorithm safely rules out pulmonary embolism in pregnant women while avoiding CT pulmonary angiography in 39% of patients, and low-molecular-weight heparin remains the first-choice treatment.
Synapse has enriched 10 related papers. Consider them for comparative context: